We report an approach for the intramolecular C(sp 2 )ÀH amidation of N-acyloxyamides under photoredox conditions to produce d-benzolactams with an aryl-alkyl sbond relocation. Computational studies on the designed reductive single electron transfer strategy led us to identify N-[3,5-bis(trifluoromethyl)benzoyl] group as the most effective amidyl radical precursor. Upon the formation of an azaspirocyclic radical intermediate by the selective ipso-addition with outcompeting an ortho-attack, radical-polar crossover was then rationalized to lead to the rearomative ring-expansion with preferential C À C bond migration.Scheme 1. Radical-polar crossover to access rearomative cyclization products via a radical ipso-addition.
We report herein a series of tailored
CpXRh(LX)Cl catalyst
systems for the outer-sphere C–H amidations discovered by high-throughput
experimentation. Using a diverse repertoire of Cp-tunable group 9
[CpXMCl2]2 precatalysts in combination
with bidentate LX-type co-ligands, we have established a premixing
protocol for the fast and convenient in situ generation
of an array of half-sandwich metal complexes. Benefitting from the
designed multidimensional approach to simultaneously screen the metal
center, CpX, LX-type co-ligands, and nitrene precursors,
optimal CpXRh(III)(LX) catalysts were quickly identified
for intra- and intermolecular C–H amidations and also for an
enantioselective transformation using N-tosyloxycarbamates
as the nitrenoid precursor.
Cyclic volatile methyl siloxanes (cVMS) are anthropogenic chemicals emitted by consumer and industrial products. Evidence from laboratory and ambient studies indicates that cVMS contributes to the formation of secondary organosiloxane...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.